Follow
Antonia Dannheim
Antonia Dannheim
Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM
Verified email at item.fraunhofer.de
Title
Cited by
Cited by
Year
Customization of Aspergillus niger morphology through addition of talc micro particles
T Wucherpfennig, A Lakowitz, H Driouch, R Krull, C Wittmann
JoVE (Journal of Visualized Experiments), e4023, 2012
422012
Mini review: recombinant production of tailored bio-pharmaceuticals in different Bacillus strains and future perspectives
A Lakowitz, T Godard, R Biedendieck, R Krull
European Journal of Pharmaceutics and Biopharmaceutics 126, 27-39, 2018
322018
Comprehension of viscous morphology—evaluation of fractal and conventional parameters for rheological characterization of Aspergillus niger culture broth
T Wucherpfennig, A Lakowitz, R Krull
Journal of biotechnology 163 (2), 124-132, 2013
292013
Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
A Lakowitz, R Krull, R Biedendieck
Microbial cell factories 16, 1-18, 2017
232017
Characterization of Clostridioides difficile DSM 101085 with ABCDT+ Phenotype from a Late Recurrent Colonization
T Riedel, M Neumann-Schaal, J Wittmann, I Schober, JD Hofmann, ...
Genome Biology and Evolution 12 (5), 566-577, 2020
92020
Integrated in situ-purification of recombinant proteins from Bacillus megaterium cultivation using SPION in stirred tank reactors
J Gädke, JW Thies, L Kleinfeldt, A Kalinin, G Starke, A Lakowitz, ...
Biochemical Engineering Journal 126, 58-67, 2017
82017
Repetitive Exposure to Bacteriophage Cocktails against Pseudomonas aeruginosa or Escherichia coli Provokes Marginal Humoral Immunity in Naïve Mice
C Weissfuss, SM Wienhold, M Bürkle, B Gaborieau, J Bushe, U Behrendt, ...
Viruses 15 (2), 387, 2023
32023
Bakteriophagen als Wirkstoffe zur Infektionsbehandlung-was ist möglich?
A Dannheim, S Hebecker, S Wienecke, H Ziehr
22020
Recombinant production of the antibody fragment D1. 3scFv in Bacillus sp.
A Lakowitz, R Biedendieck, R Krull
New Biotechnology, S195, 2016
22016
A phage cocktail against Pseudomonas aeruginosa lung infection: results from experimental studies
MC Brack, M Vollgraf, G Nouailles, I Korf, S Wienecke, A Dannheim, ...
European Respiratory Journal 60 (suppl 66), 2022
12022
Phage manufacturing process for an old therapy in new clothes
A Dannheim, I Korf, S Wienecke, H Ziehr
PHARMAKON 9 (6), 446-453, 2021
12021
Combining a phage cocktail with antibiotics improves recovery from Pseudomonas-induced VAP in mice
C Weißfuß, J Li, U Behrendt, M Bürkle, B Gaborieau, I Korf, S Wienecke, ...
Pneumologie 78 (S 01), Po 407, 2024
2024
Phage4Cure–ex vivo and in vivo efficacy testing of a phage cocktail against Pseudomonas aeruginosa
MC Brack, M Vollgraf, G Nouailles, I Korf, S Wienecke, A Dannheim, ...
Pneumologie 76 (S 01), FV 390, 2022
2022
Biomorphological and related technical aspects affecting phage activity for inhaled application
SM Wienhold, MC Brack, W Groenewald, G Nouailles, I Korf, M Rohde, ...
European Respiratory Journal 56 (suppl 64), 2020
2020
Bacteriophages as active substances for the treatment of infections–what is possible?
A Dannheim, S Hebecker, S Wienecke, H Ziehr
PHARMAKON 8 (4), 278-284, 2020
2020
Impact of phage morphologies on titer reduction due to nebulization–a blueprint for clinical application
SM Wienhold, MC Brack, W Groenewald, G Nouailles, I Korf, M Rohde, ...
Pneumologie 74 (S 01), P388, 2020
2020
Skalenübergreifende Produktion und Sekretion rekombinanter Proteine mit Stämmen der Gattung Bacillus
A Lakowitz
Dissertation - Schriftenreihe des Institutes für Bioverfahrenstechnik der …, 2017
2017
Kennzahlen aus automatischer Bildanalyse zur Abschätzung der Viskosität in biotechnologischen Prozessen mit filamentösen Pilzen
T Wucherpfennig, A Lakowitz, R Krull
Chemie Ingenieur Technik 84 (8), 1375-1375, 2012
2012
Characterization of Clostridioides difficile DSM 101085 with A 2 B 2 CDT Phenotype from a Late Recurrent Colonization
T Riedel, M Neumann-Schaal, J Wittmann, I Schober, J Danielle, ...
The system can't perform the operation now. Try again later.
Articles 1–19